Los Angeles, United States
CellBri, founded in 2020, is making significant strides in the biotechnology sector with its focus on advanced manufacturing solutions for cell therapies. Operating under the slogan, "Your Cell Therapy. Automated Your Way.", the company specializes in developing automated, closed, digital, and regulatory-compliant systems crucial for cell processing and fill-and-finish operations.
Headquartered in the United States with strong international presence in Shenzhen, China, as well as facilities in Beijing, Shanghai, and Research Triangle Park, North Carolina, CellBri presents a dual advantage of global accessibility and regional expertise. Their solutions are designed to empower academic institutions, biotechnology firms, and pharmaceutical companies by accelerating drug development, enhancing manufacturing efficiency, reducing process failures, lowering production costs, and meeting global patient demands.
Despite being relatively new, CellBri has yet to announce a significant round of investment, positioning it as a compelling prospect for venture capitalists seeking to enter or expand within the burgeoning cell therapy market.
